This compensatory mechanism is evident in the dynamic interplay between the SMURF2-HIF1α pathway and HSPs, where HSP-70 influences cellular responses to hypoxia and affects lung cancer recurrence, particularly following treatments such as radiofrequency ablation (81). Here, HIF1A is linked to lung carcinoma.